FARMINGDALE, N.Y., Nov. 11, 2010 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, today announced plans to release first quarter ended September 30, 2010 financial results on Monday, November 15, 2010. Michael A. McManus, President and Chief Executive Officer and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Monday, November 15, 2010 to discuss the Company's first quarter 2011 financial results.
Shareholders and other interested parties may participate in the conference call by dialing (800) 706-7741 (domestic) or (617) 614-3471 (international) and entering access code 84227160, a few minutes before the start of the call. A simultaneous webcast will be available via Misonix's website at www.misonix.com. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available approximately 2 hours after the event through November 22, 2010. The dial-in number to listen to the recording is (888) 286-8010 or (617) 801-6888. The replay access code is 31342240.
About Misonix:Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for spine surgery, wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.Investor Relations Contact:Kevin M. McGrathCameron Associates, Inc.212 245 4577Kevin@cameronassoc.com
|SOURCE Misonix, Inc.|
Copyright©2010 PR Newswire.
All rights reserved